Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Moleculin Biotech Inc.

    NASDAQ: MBRX · Real-Time Price · USD
    0.64
    -0.03 (-4.26%)
    At close: Jun 13, 2025, 3:59 PM
    0.66
    2.87%
    After-hours: Jun 13, 2025, 05:57 PM EDT

    Moleculin Biotech Statistics

    Share Statistics

    Moleculin Biotech has 14.13M shares outstanding. The number of shares has increased by 505.68% in one year.

    Shares Outstanding

    n/a
    		 14.13M

    Shares Change (YoY)

    n/a
    		 505.68%

    Shares Change (QoQ)

    n/a
    		 338.76%

    Owned by Institutions (%)

    n/a
    		 13.5%

    Shares Floating

    n/a
    		 14.01M

    Failed to Deliver (FTD) Shares

    n/a
    		 10,937

    FTD / Avg. Volume

    n/a
    		 1.79%

    Short Selling Information

    The latest short interest is 602.99K, so 4.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 602.99K

    Short % of Shares Out

    n/a
    		 4.27%

    Short % of Float

    n/a
    		 4.3%

    Short Ratio (days to cover)

    n/a
    		 3.06

    Valuation Ratios

    The PE ratio is -0.27 and the forward PE ratio is -0.38. Moleculin Biotech's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.27

    Forward PE

    n/a
    		 -0.38

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.98

    P/FCF Ratio

    n/a
    		 -0.25

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Moleculin Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 0.97

    Quick Ratio

    n/a
    		 0.97

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,280,176.47

    Employee Count

    n/a
    		 17

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -84.54% in the last 52 weeks. The beta is 1.56, so Moleculin Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.56

    52-Week Price Change

    n/a
    		 -84.54%

    50-Day Moving Average

    n/a
    		 0.9

    200-Day Moving Average

    n/a
    		 1.71

    Relative Strength Index (RSI)

    n/a
    		 29.97

    Average Volume (20 Days)

    n/a
    		 610,650

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -26.64M

    Net Income

    n/a
    		 -21.76M

    EBITDA

    n/a
    		 -21.64M

    EBIT

    n/a
    		 -21.76M

    Earnings Per Share (EPS)

    n/a
    		 -6.32
    Full Income Statement

    Balance Sheet

    The company has 4.28M in cash and 478K in debt, giving a net cash position of 3.8M.

    Cash & Cash Equivalents

    n/a
    		 4.28M

    Total Debt

    n/a
    		 478K

    Net Cash

    n/a
    		 3.8M

    Retained Earnings

    n/a
    		 -153.37M

    Total Assets

    n/a
    		 21.01M

    Working Capital

    n/a
    		 2.44M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -23.86M and capital expenditures -13K, giving a free cash flow of -23.88M.

    Operating Cash Flow

    n/a
    		 -23.86M

    Capital Expenditures

    n/a
    		 -13K

    Free Cash Flow

    n/a
    		 -23.88M

    FCF Per Share

    n/a
    		 -6.93
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MBRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MBRX is $4, which is 525% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 525%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 22, 2024. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Mar 22, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -14.21

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist